Articles:

I Bouchelet, Z Cohen, B Case, P Seguela, and E Hamel

Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels
Mol Pharmacol 1996 50: 219-223. [Abstract] [PDF]  

RA Nicholas, WC Watt, ER Lazarowski, Q Li, and K Harden

Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor
Mol Pharmacol 1996 50: 224-229. [Abstract] [PDF]  

SR Glaum, M Hara, VP Bindokas, CC Lee, KS Polonsky, GI Bell, and RJ Miller

Leptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus
Mol Pharmacol 1996 50: 230-235. [Abstract] [PDF]  

T Yazaki, S Ahmad, A Chahlavi, E Zylber-Katz, NM Dean, SD Rabkin, RL Martuza, and RI Glazer

Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide
Mol Pharmacol 1996 50: 236-242. [Abstract] [PDF]  

R Ganapathi, A Constantinou, N Kamath, G Dubyak, D Grabowski, and K Krivacic

Resistance to etoposide in human leukemia HL-60 cells: reduction in drug-induced DNA cleavage associated with hypophosphorylation of topoisomerase II phosphopeptides
Mol Pharmacol 1996 50: 243-248. [Abstract] [PDF]  

CP Tseng and AK Verma

Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase activity by genistein, a tyrosine kinase inhibitor
Mol Pharmacol 1996 50: 249-257. [Abstract] [PDF]  

TE Webb, D Henderson, BF King, S Wang, J Simon, AN Bateson, G Burnstock, and EA Barnard

A novel G protein-coupled P2 purinoceptor (P2Y3) activated preferentially by nucleoside diphosphates
Mol Pharmacol 1996 50: 258-265. [Abstract] [PDF]  

HE Melikian, S Ramamoorthy, CG Tate, and RD Blakely

Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition
Mol Pharmacol 1996 50: 266-276. [Abstract] [PDF]  

DL Duval, DR Miller, J Collier, and RE Billings

Characterization of hepatic nitric oxide synthase: identification as the cytokine-inducible form primarily regulated by oxidants
Mol Pharmacol 1996 50: 277-284. [Abstract] [PDF]  

M Sautel, K Rudolf, H Wittneben, H Herzog, R Martinez, M Munoz, W Eberlein, W Engel, P Walker, and AG Beck-Sickinger

Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor
Mol Pharmacol 1996 50: 285-292. [Abstract] [PDF]  

KM Standifer, GC Rossi, and GW Pasternak

Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein alpha subunits
Mol Pharmacol 1996 50: 293-298. [Abstract] [PDF]  

EM Sutkowski, JD Robbins, WJ Tang, and KB Seamon

Irreversible inhibition of forskolin interactions with type I adenylyl cyclase by a 6-isothiocyanate derivative of forskolin
Mol Pharmacol 1996 50: 299-305. [Abstract] [PDF]  

SA Berry, MC Shah, N Khan, and BL Roth

Rapid agonist-induced internalization of the 5-hydroxytryptamine2A receptor occurs via the endosome pathway in vitro
Mol Pharmacol 1996 50: 306-313. [Abstract] [PDF]  

JM Coulson, DR Poyner, A Chantry, WJ Irwin, and S Akhtar

A nonantisense sequence-selective effect of a phosphorothioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells
Mol Pharmacol 1996 50: 314-325. [Abstract] [PDF]  

S Lecoeur, C Andre, and PH Beaune

Tienilic acid-induced autoimmune hepatitis: anti-liver and-kidney microsomal type 2 autoantibodies recognize a three-site conformational epitope on cytochrome P4502C9
Mol Pharmacol 1996 50: 326-333. [Abstract] [PDF]  

YJ Jeon, KH Yang, JT Pulaski, and NE Kaminski

Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation
Mol Pharmacol 1996 50: 334-341. [Abstract] [PDF]  

E Hedlund, A Wyss, T Kainu, M Backlund, C Kohler, M Pelto-Huikko, JA Gustafsson, and M Warner

Cytochrome P4502D4 in the brain: specific neuronal regulation by clozapine and toluene
Mol Pharmacol 1996 50: 342-350. [Abstract] [PDF]  

SM Wade, MK Scribner, HM Dalman, JM Taylor, and RR Neubig

Structural requirements for G(o) activation by receptor-derived peptides: activation and modulation domains of the alpha 2-adrenergic receptor i3c region
Mol Pharmacol 1996 50: 351-358. [Abstract] [PDF]  

CF Perno, E Balestra, S Aquaro, S Panti, A Cenci, G Lazzarino, B Tavazzi, D Di Pierro, J Balzarini, and R Calio

Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines
Mol Pharmacol 1996 50: 359-366. [Abstract] [PDF]  

FJ Azula, ES Alzola, M Conde, M Trueba, JM Macarulla, and A Marino

Thrombin-stimulated phospholipase C activity is inhibited without visible delay by a rapid increase in the cyclic GMP levels induced by sodium nitroprusside
Mol Pharmacol 1996 50: 367-379. [Abstract] [PDF]  

J Kiehn, B Wible, AE Lacerda, and AM Brown

Mapping the block of a cloned human inward rectifier potassium channel by dofetilide
Mol Pharmacol 1996 50: 380-387. [Abstract] [PDF]  

SY Yao, CE Cass, and JD Young

Transport of the antiviral nucleoside analogs 3'-azido-3'- deoxythymidine and 2',3'-dideoxycytidine by a recombinant nucleoside transporter (rCNT) expressed in Xenopus laevis oocytes
Mol Pharmacol 1996 50: 388-393. [Abstract] [PDF]  

J Balzarini, H Pelemans, S Aquaro, CF Perno, M Witvrouw, D Schols, E De Clercq, and A Karlsson

Highly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication
Mol Pharmacol 1996 50: 394-401. [Abstract] [PDF]  

MP Mascia, SJ Mihic, CF Valenzuela, PR Schofield, and RA Harris

A single amino acid determines differences in ethanol actions on strychnine-sensitive glycine receptors
Mol Pharmacol 1996 50: 402-406. [Abstract] [PDF]  

FA Gesek

Alpha 2-adrenergic receptors activate phospholipase C in renal epithelial cells
Mol Pharmacol 1996 50: 407-414. [Abstract] [PDF]  

W Beindl, T Mitterauer, M Hohenegger, AP Ijzerman, C Nanoff, and M Freissmuth

Inhibition of receptor/G protein coupling by suramin analogues
Mol Pharmacol 1996 50: 415-423. [Abstract] [PDF]  

GS Bogatkewitsch, W Lenz, KH Jakobs, and CJ Van Koppen

Receptor internalization delays m4 muscarinic acetylcholine receptor resensitization at the plasma membrane
Mol Pharmacol 1996 50: 424-429. [Abstract] [PDF]  

LJ Olson, DG Lowe, and JG Drewett

Novel natriuretic peptide receptor/guanylyl cyclase A-selective agonist inhibits angiotensin II- and forskolin-evoked aldosterone synthesis in a human zona glomerulosa cell line
Mol Pharmacol 1996 50: 430-435. [Abstract] [PDF]  

F Schmitz, DS Pratt, MJ Wu, LF Jr Kolakowski, M Beinborn, and AS Kopin

Identification of cholecystokinin-B/gastrin receptor domains that confer high gastrin affinity: utilization of a novel Xenopus laevis cholecystokinin receptor
Mol Pharmacol 1996 50: 436-441. [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.